Koshinski Asset Management Inc. purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 1,483 shares of the semiconductor company’s stock, valued at approximately $732,000.
A number of other institutional investors have also recently added to or reduced their stakes in SNPS. Alpine Bank Wealth Management increased its stake in shares of Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 25 shares during the last quarter. TFC Financial Management Inc. grew its holdings in shares of Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after purchasing an additional 50 shares during the period. Millstone Evans Group LLC acquired a new stake in Synopsys during the third quarter worth about $27,000. SOA Wealth Advisors LLC. purchased a new position in Synopsys during the third quarter worth about $28,000. Finally, McIlrath & Eck LLC acquired a new position in Synopsys in the 3rd quarter valued at about $29,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Trading Down 4.3%
SNPS opened at $420.82 on Tuesday. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The business has a fifty day simple moving average of $473.38 and a 200-day simple moving average of $480.49. The firm has a market cap of $80.61 billion, a P/E ratio of 52.67, a P/E/G ratio of 3.66 and a beta of 1.12.
Wall Street Analyst Weigh In
SNPS has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. lifted their price target on shares of Synopsys from $600.00 to $650.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. KeyCorp upped their price target on Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research note on Thursday, December 11th. Needham & Company LLC raised their price objective on Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Finally, Piper Sandler cut shares of Synopsys from an “overweight” rating to a “neutral” rating and decreased their target price for the company from $602.00 to $520.00 in a research report on Tuesday, January 13th. Nine equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $547.00.
Get Our Latest Research Report on SNPS
Insider Activity at Synopsys
In related news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares in the company, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 4,157 shares of company stock valued at $1,945,036. Insiders own 0.62% of the company’s stock.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Silver $500? The “Deficit Math” says it’s possible.
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
